430 related articles for article (PubMed ID: 28060997)
1. Effect of hypercholesterolaemia on myocardial function, ischaemia-reperfusion injury and cardioprotection by preconditioning, postconditioning and remote conditioning.
Andreadou I; Iliodromitis EK; Lazou A; Görbe A; Giricz Z; Schulz R; Ferdinandy P
Br J Pharmacol; 2017 Jun; 174(12):1555-1569. PubMed ID: 28060997
[TBL] [Abstract][Full Text] [Related]
2. Myocardial ischaemia reperfusion injury and cardioprotection in the presence of sensory neuropathy: Therapeutic options.
Bencsik P; Gömöri K; Szabados T; Sántha P; Helyes Z; Jancsó G; Ferdinandy P; Görbe A
Br J Pharmacol; 2020 Dec; 177(23):5336-5356. PubMed ID: 32059259
[TBL] [Abstract][Full Text] [Related]
3. Interaction of cardiovascular risk factors with myocardial ischemia/reperfusion injury, preconditioning, and postconditioning.
Ferdinandy P; Schulz R; Baxter GF
Pharmacol Rev; 2007 Dec; 59(4):418-58. PubMed ID: 18048761
[TBL] [Abstract][Full Text] [Related]
4. Effect of hyperglycaemia and diabetes on acute myocardial ischaemia-reperfusion injury and cardioprotection by ischaemic conditioning protocols.
Penna C; Andreadou I; Aragno M; Beauloye C; Bertrand L; Lazou A; Falcão-Pires I; Bell R; Zuurbier CJ; Pagliaro P; Hausenloy DJ
Br J Pharmacol; 2020 Dec; 177(23):5312-5335. PubMed ID: 31985828
[TBL] [Abstract][Full Text] [Related]
5. Hyperlipidaemia and cardioprotection: Animal models for translational studies.
Andreadou I; Schulz R; Badimon L; Adameová A; Kleinbongard P; Lecour S; Nikolaou PE; Falcão-Pires I; Vilahur G; Woudberg N; Heusch G; Ferdinandy P
Br J Pharmacol; 2020 Dec; 177(23):5287-5311. PubMed ID: 31769007
[TBL] [Abstract][Full Text] [Related]
6. Interaction of Cardiovascular Nonmodifiable Risk Factors, Comorbidities and Comedications With Ischemia/Reperfusion Injury and Cardioprotection by Pharmacological Treatments and Ischemic Conditioning.
Ferdinandy P; Andreadou I; Baxter GF; Bøtker HE; Davidson SM; Dobrev D; Gersh BJ; Heusch G; Lecour S; Ruiz-Meana M; Zuurbier CJ; Hausenloy DJ; Schulz R
Pharmacol Rev; 2023 Jan; 75(1):159-216. PubMed ID: 36753049
[TBL] [Abstract][Full Text] [Related]
7. Endogenous cardioprotection by ischaemic postconditioning and remote conditioning.
Shi W; Vinten-Johansen J
Cardiovasc Res; 2012 May; 94(2):206-16. PubMed ID: 22323534
[TBL] [Abstract][Full Text] [Related]
8. Molecular basis of cardioprotection: signal transduction in ischemic pre-, post-, and remote conditioning.
Heusch G
Circ Res; 2015 Feb; 116(4):674-99. PubMed ID: 25677517
[TBL] [Abstract][Full Text] [Related]
9. Signaling mediators modulated by cardioprotective interventions in healthy and diabetic myocardium with ischaemia-reperfusion injury.
Saeid F; Aniseh J; Reza B; Manouchehr VS
Eur J Prev Cardiol; 2018 Sep; 25(14):1463-1481. PubMed ID: 29442529
[TBL] [Abstract][Full Text] [Related]
10. What is Wrong With Cardiac Conditioning? We May be Shooting at Moving Targets.
Iliodromitis EK; Cohen MV; Dagres N; Andreadou I; Kremastinos DT; Downey JM
J Cardiovasc Pharmacol Ther; 2015 Jul; 20(4):357-69. PubMed ID: 25627214
[TBL] [Abstract][Full Text] [Related]
11. Pathophysiology of myocardial reperfusion injury: preconditioning, postconditioning, and translational aspects of protective measures.
Sanada S; Komuro I; Kitakaze M
Am J Physiol Heart Circ Physiol; 2011 Nov; 301(5):H1723-41. PubMed ID: 21856909
[TBL] [Abstract][Full Text] [Related]
12. Rapid ventricular pacing-induced postconditioning attenuates reperfusion injury: effects on peroxynitrite, RISK and SAFE pathways.
Pipicz M; Varga ZV; Kupai K; Gáspár R; Kocsis GF; Csonka C; Csont T
Br J Pharmacol; 2015 Jul; 172(14):3472-83. PubMed ID: 25827015
[TBL] [Abstract][Full Text] [Related]
13. Inhalational anaesthetics and cardioprotection.
Weber NC; Schlack W
Handb Exp Pharmacol; 2008; (182):187-207. PubMed ID: 18175092
[TBL] [Abstract][Full Text] [Related]
14. Preconditioning and postconditioning: underlying mechanisms and clinical application.
Hausenloy DJ; Yellon DM
Atherosclerosis; 2009 Jun; 204(2):334-41. PubMed ID: 19081095
[TBL] [Abstract][Full Text] [Related]
15. The role of gasotransmitters NO, H2S and CO in myocardial ischaemia/reperfusion injury and cardioprotection by preconditioning, postconditioning and remote conditioning.
Andreadou I; Iliodromitis EK; Rassaf T; Schulz R; Papapetropoulos A; Ferdinandy P
Br J Pharmacol; 2015 Mar; 172(6):1587-606. PubMed ID: 24923364
[TBL] [Abstract][Full Text] [Related]
16. Time to Give Up on Cardioprotection? A Critical Appraisal of Clinical Studies on Ischemic Pre-, Post-, and Remote Conditioning.
Heusch G; Rassaf T
Circ Res; 2016 Aug; 119(5):676-95. PubMed ID: 27539973
[TBL] [Abstract][Full Text] [Related]
17. Ischaemic conditioning and reperfusion injury.
Hausenloy DJ; Yellon DM
Nat Rev Cardiol; 2016 Apr; 13(4):193-209. PubMed ID: 26843289
[TBL] [Abstract][Full Text] [Related]
18. Myocardial triggers involved in activation of remote ischaemic preconditioning.
Donato M; Goyeneche MA; Garces M; Marchini T; Pérez V; Del Mauro J; Höcht C; Rodríguez M; Evelson P; Gelpi RJ
Exp Physiol; 2016 Jun; 101(6):708-16. PubMed ID: 27028009
[TBL] [Abstract][Full Text] [Related]
19. Protecting the heart from ischemia/reperfusion injury: an update on remote ischemic preconditioning and postconditioning.
Donato M; Evelson P; Gelpi RJ
Curr Opin Cardiol; 2017 Nov; 32(6):784-790. PubMed ID: 28902715
[TBL] [Abstract][Full Text] [Related]
20. Endogenous Cardioprotective Agents: Role in Pre and Postconditioning.
Penna C; Granata R; Tocchetti CG; Gallo MP; Alloatti G; Pagliaro P
Curr Drug Targets; 2015; 16(8):843-67. PubMed ID: 25751010
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]